Rise of illegal puberty blockers market in the UK targets teens
Drug traffickers have found a profitable market in puberty blockers, heavily marketed by advocates of progressive “woke” culture. This has led to the establishment of a black market in the United Kingdom, aimed at transgender adolescents or those identifying as such.
Young individuals are now purchasing these blockers from international suppliers via the internet, circumventing traditional legal and medical safeguards. Social media platforms such as Reddit, X, and Facebook serve as hubs where vendors distribute links to websites that sell these drugs without requiring age verification or prescriptions.
The severity of this issue came to light when a The Mail on Sunday journalist, posing as a teenager, successfully ordered a significant quantity of puberty blockers from Turkey, Hong Kong, and Russia. These online “pharmacies” offer the drugs at prices ranging from $52 to $228 and promote incentives like “express delivery” or Bitcoin payment discounts.
Reactions from UK health authorities about the puberty blockers
UK Health Secretary Victoria Atkins responded to the revelations with grave concern. She praised The Mail on Sunday for their critical public interest journalism and vowed to explore legislative measures to halt these online sales. Former Health Secretary Sajid Javid also voiced concerns, stressing that “these powerful medications were never meant to be available on demand,” and pointing out the risks to thousands of children.
Conservative MP Paul Bristow expressed that this situation represents “every parent’s worst nightmare,” highlighting the potential irreversible harm to minors. Additionally, Transgender Trend, an organization of concerned parents, professionals, and academics, has urged the government to take immediate action to dismantle this black market. They also called for preventative measures in schools to stop promoting ideologies that mislead children into thinking they need these medications.
The misuse of puberty blockers led the UK’s National Health Service (NHS) to ban these treatments for individuals under 18 in March. This decision followed extensive evidence of their adverse effects, notably highlighted by problematic practices at the Tavistock clinic in London, which faced closure after multiple patient lawsuits.
Dr. Hilary Cass’s report for the British government underscored the dangers these drugs pose to children, emphasizing the lack of evidence about their long-term impacts. This investigation underscores the need for evidence-based approaches to transgender youth treatment and stringent controls over medication distribution.
